Left ventricular dysfunction in relation with systemic inflammation in chronic obstructive pulmonary disease patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Most important cause of mortality in chronic obstructive pulmonary disease (COPD) patients is known to be cardiovascular disease (CVD). The objective of the present study was to evaluate the echocardiographic parameters in COPD patients with or without pre-diagnosed CVD and to investigate the relationship between echocardiographic parameters and systemic inflammation markers. Methods: A total of 60 stable COPD patients (23 patients with CVD, group 1; 37 patients without CVD, group 2) and 21 healthy controls (group 3) were included in the study. Six-minute walking test (6MWT), COPD assessment test (CAT), and Body mass index, airflow Obstruction, Dyspnea, and Exercise (BODE) index results were recorded. High-sensitivity C-reactive protein (HsCRP), interleukin 8 (IL-8), fetuin-A, Clara cell protein (CCL-16), N-terminal pro-brain natriuretic peptide levels were studied in serum. Parameters of left and right ventricular systolic and diastolic function were measured by echocardiography. Results: Patients with COPD had higher levels of systemic inflammation markers and lower level of inflammation inhibitor fetuin-A. When three groups were compared, group 1 had lower 6MWT result. HsCRP was highest in group 2 while other inflammatory markers were similar in groups 1 and 2. Regarding echocardiographic parameters, left ventricular ejection fraction (LVEF) was lower and left ventricle end-diastolic diameter (LVED), left ventricle end-systolic diameter (LVES) diameters were higher in group 1. The aortic diameter was higher in COPD patients. Fetuin-A was correlated with diameter of aorta and LVES. LVEF, LVED, and LVES were found to be correlated with functional parameters of COPD cases. Conclusions: In COPD, left ventricular functions are affected as well as right ventricle before prominent clinical findings of cardiac disease and these echocardiographic parameters correlate with functional parameters of COPD patients.
Abstract
Background/Aims: Most important cause of mortality in chronic obstructive pulmonary disease (COPD) patients is known to be cardiovascular disease (CVD). The objective of the present study was to evaluate the echocardiographic parameters in COPD patients with or without pre-diagnosed CVD and to investigate the relationship between echocardiographic parameters and systemic inflammation markers. Methods: A total of 60 stable COPD patients (23 patients with CVD, group 1; 37 patients without CVD, group 2) and 21 healthy controls (group 3) were included in the study. Six-minute walking test (6MWT), COPD assessment test (CAT), and Body mass index, airflow Obstruction, Dyspnea, and Exercise (BODE) index results were recorded. High-sensitivity C-reactive protein (HsCRP), interleukin 8 (IL-8), fetuin-A, Clara cell protein (CCL-16), N-terminal pro-brain natriuretic peptide levels were studied in serum. Parameters of left and right ventricular systolic and diastolic function were measured by echocardiography. Results: Patients with COPD had higher levels of systemic inflammation markers and lower level of inflammation inhibitor fetuin-A. When three groups were compared, group 1 had lower 6MWT result. HsCRP was highest in group 2 while other inflammatory markers were similar in groups 1 and 2. Regarding echocardiographic parameters, left ventricular ejection fraction (LVEF) was lower and left ventricle end-diastolic diameter (LVED), left ventricle end-systolic diameter (LVES) diameters were higher in group 1. The aortic diameter was higher in COPD patients. Fetuin-A was correlated with diameter of aorta and LVES. LVEF, LVED, and LVES were found to be correlated with functional parameters of COPD cases. Conclusions: In COPD, left ventricular functions are affected as well as right ventricle before prominent clinical findings of cardiac disease and these echocardiographic parameters correlate with functional parameters of COPD patients.
참고문헌 (35)
- Vestbo J, "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease : GOLD executive summary", Am J Respir Crit Care Med, 187, pp.347~365 (2013)
- Fabbri LM, "Complex chronic comorbidities of COPD", Eur Respir J, 31, pp.204~212 (2008)
- Barnes PJ, "Systemic manifestations and comorbidities of COPD", Eur Respir J, 33, pp.1165~1185 (2009)
- Back M, "Atherosclerosis, COPD and chronic inflammation", Respir Med COPD Update, 4, pp.60~65 (2008)
- Sin DD, "Chronic obstructive pulmonary disease : a novel risk factor for cardiovascular disease", Can J Physiol Pharmacol, 83, pp.8~13 (2005)
- Boschetto P, "Link between chronic obstructive pulmonary disease and coronary artery disease : implication for clinical practice", Respirology, 17, pp.422~431 (2012)
- Chen YR, "C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations", PLoS One, 12, pp.e0174063~ (2017)
- Kazmierczak M, "Evaluation of markers of ınflammation and oxidative stress in COPD patients with or without cardiovascular comorbidities", Heart Lung Circ, 24, pp.817~823 (2015)
- Lock-Johansson S, "Surfactant protein D, club cell protein 16, pulmonary and activation-regulated chemokine, C-reactive protein, and fibrinogen biomarker variation in chronic obstructive lung disease", Respir Res, 15, pp.147~ (2014)
- Adrish M, "Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction", Int J Chron Obstruct Pulmon Dis, 12, pp.1183~1189 (2017)
- Lim P, "Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction", Clin Chem, 53, pp.1835~1840 (2007)
- Bilgir O, "Decreased serum fetuin-A levels are associated with coronary artery diseases", Intern Med, 49, pp.1281~1285 (2010)
- Ponikowski P, "2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure : the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)developed with the special contribution of the Heart Failure Association(HFA)of the ESC", Eur Heart J, 37, pp.2129~2200 (2016)
- Rabe KF, "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease : GOLD executive summary", Am J Respir Crit Care Med, 176, pp.532~555 (2007)
- Miller MR, "General considerations for lung function testing", Eur Respir J, 26, pp.153~161 (2005)
- "GOLD 2017 Global strategy for the diagnosis, management and prevention of COPD" (2018)[URL]
- Lang RM, "Recommendations for chamber quantification : a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology", J Am Soc Echocardiogr, 18, pp.1440~1463 (2005)
- Keaney JF Jr, "Obesity and systemic oxidative stress : clinical correlates of oxidative stress in the Framingham Study", Arterioscler Thromb Vasc Biol, 23, pp.434~439 (2003)
- Rutten FH, "Heart failure and chronic obstructive pulmonary disease: an ignored combination?", Eur J Heart Fail, 8, pp.706~711 (2006)
- Gulen ST, "Adipokines and systemic inflammation in weight-losing lung cancer patients", Lung, 190, pp.327~332 (2012)
- Agusti AG, "Systemic effects of chronic obstructive pulmonary disease", Eur Respir J, 21, pp.347~360 (2003)
- Khan NA, "Evaluation of BODE index and its relationship with systemic inflammation mediated by proinflammatory biomarkers in patients with COPD", J Inflamm Res, 9, pp.187~198 (2016)
- Gan WQ, "Association between chronic obstructive pulmonary disease and systemic inflammation : a systematic review and a meta-analysis", Thorax, 59, pp.574~580 (2004)
- Pinto-Plata VM, "C-reactive protein in patients with COPD, control smokers and non-smokers", Thorax, 61, pp.23~28 (2006)
- Beghe B, "Echocardiography, spirometry, and systemic acute-phase inflammatory proteins in smokers with COPD or CHF : an observational study", PLoS One, 8, pp.e80166~ (2013)
- Hawkins NM, "B-type natriuretic peptides in chronic obstructive pulmonary disease : a systematic review", BMC Pulm Med, 17, pp.11~ (2017)
- Pavasini R, "Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease : systematic review and meta-analysis", Chron Respir Dis, 14, pp.117~126 (2017)
- Minas M, "Fetuin-A is associated with disease severity and exacerbation frequency in patients with COPD", COPD, 10, pp.28~34 (2013)
- Alpsoy S, "Serum fetuin-A levels are associated with carotid intima-media thickness in patients with normotensive chronic obstructive pulmonary disease", Cardiol J, 21, pp.191~197 (2014)
- Tannus-Silva DG, "State of the art review of the right ventricle in COPD patients : ıt is time to look closer", Lung, 195, pp.9~17 (2017)
- Kazmierczak M, "Correlation of inflammatory markers with echocardiographic parameters of left and right ventricular function in patients with chronic obstructive pulmonary disease and cardiovascular diseases", Pol Arch Med Wewn, 124, pp.290~297 (2014)
- Pela G, "Left ventricular structure and remodeling in patients with COPD", Int J Chron Obstruct Pulmon Dis, 11, pp.1015~1022 (2016)
- Huang YS, "Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients", Clin Interv Aging, 10, pp.81~87 (2014)
- Inoue S, "Decreased left ventricular stroke volume is associated with low-grade exercise tolerance in patients with chronic obstructive pulmonary disease", BMJ Open Respir Res, 4, pp.e000158~ (2017)
- Schoos MM, "Echocardiographic predictors of exercise capacity and mortality in chronic obstructive pulmonary disease", BMC Cardiovasc Disord, 13, pp.84~ (2013)